
Veeam has been acquired by private equity firm Insight Partners for around US$5 billion, in a move which will see the vendor “become a US company.”
Veeam’s management has also been overhauled, with co-founders Andrei Baronov—who is also CEO—and Ratmir Timashev leaving the firm.
Executive vice president of operations William Largent will step up to the chief executive role, creating a “US-based management team.”
“Veeam has enjoyed rapid global growth over the last decade and we see tremendous opportunity for future growth, particularly in the US market,” the new boss said.
“With the acquisition, we are excited that our current US workforce of more than 1,200 will be expanded and strengthened to acquire and support more customers.”
Switzerland-based Veeam was founded by Baronov and Timashev after the pair sold their previous company, Aelita Software, to Quest for around US$115 million. New Veeam CEO Largent had been COO at Aelita.
Insight managing director Mike Triplett, who is now a Veeam board member, said, “Veeam’s strong growth, coupled with high customer retention, unparalleled data management solutions and the opportunities to expand services into new markets, make it one of the most exciting software companies in the world today.
“We are committed to supporting Veeam’s next phase of leadership and growth in the US, continued market-share leadership position in EMEA and continued global expansion.”
Full Content: Channel Web
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
EU and UK Finalize Deal to Strengthen Antitrust Cooperation
May 20, 2025 by
CPI
Clemens Food Group Reaches $13.5 Million Settlement in Pork Price-Fixing Suit
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas